Abstract
The aim of our prospective case-control study was to evaluate long-term effects of GH replacement therapy on erythrocytes parameters, leukocytes, and platelets numbers in a large cohort of children with isolated GH deficiency (GHD). Hemoglobin (Hb) concentration, hematocrit (Hct), mean corpuscular volume, mean corpuscular hemoglobin, red cell distribution width, number of erythrocytes, leukocytes, neutrophils, lymphocytes, monocytes and platelets, ferritin, and C-reactive protein were evaluated in 85 children with isolated GHD (10.20 ± 3.50 years) before and annually during the first 5 years of GH replacement therapy and in 85 healthy children age and sex comparable to patients during 5 years of follow-up. Compared with controls, GHD children at study entry showed lower Hb (−1.18 ± 0.87 vs. −0.40 ± 0.90 SDS, p < 0.0001), red cells number (−0.24 ± 0.81 vs. 0.25 ± 1.14 SDS, p < 0.0001), and Hct (−1.18 ± 0.86 vs. −0.68 ± 0.99 SDS, p < 0.0001). Twelve GHD patients (14 %) showed a normocytic anemia. GH therapy was associated with a significant increase in Hb, Hct, and red cells number which became all comparable to controls within the first 2 years of treatment. Moreover, hemoglobin levels normalized in all anemic GHD patients after 5 years of therapy. No difference between patients and controls was found in leukocytes and platelets numbers neither at baseline nor during the study. GHD in childhood is associated with an impairment of erythropoiesis which causes a normocytic anemia in a considerable percentage of patients. GH replacement therapy exerts a beneficial effect leading to a significant increase of erythrocytes parameters and recovery from anemia. Neither GHD nor GH replacement treatment exerts effects on leukocytes or platelets numbers.
Similar content being viewed by others
References
N. Møller, J.O. Jørgensen, Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr. Rev. 30, 152–177 (2009)
J.L. Bresson, S. Jeay, M.C. Gagnerault, C. Kayser, N. Beressi, Z. Wu, S. Kinet, M. Dardenne, M.C. Postel-Vinay, Growth hormone (GH) and prolactin receptors in human peripheral blood mononuclear cells: relation with age and GH-binding protein. Endocrinology 140, 3203–3209 (1999)
M.B. Hanley, L.A. Napolitano, J.M. McCune, Growth hormone-induced stimulation of multilineage human hematopoiesis. Stem Cells 23, 1170–1179 (2005)
D.W. Golde, N. Bersch, C.H. Li, Growth hormone: species-specific stimulation of erythropoiesis in vitro. Science 196, 1112–1113 (1977)
W.J. Murphy, S.K. Durum, M.R. Anver, D.L. Longo, Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW/J dwarf mice. J. Immunol. 148, 3799–3805 (1992)
A. Kurtz, J. Zapf, K.U. Eckardt, G. Clemons, E.R. Froesch, C. Bauer, Insulin-like growth factor I stimulates erythropoiesis in hypophysectomized rats. Proc. Natl. Acad. Sci. U. S. A. 85, 7825–7829 (1988)
G. Valerio, S. Di Maio, M. Salerno, A. Argenziano, R. Badolato, A. Tenore, Assessment of red blood cell indices in growth-hormone-treated children. Horm. Res. 47, 62–66 (1997)
M. Sohmiya, Y. Kato, Effect of long-term administration of recombinant human growth hormone (rhGH) on plasma erythropoietin (EPO) and haemoglobin levels in anaemic patients with adult GH deficiency. Clin. Endocrinol. (Oxf.) 55, 749–754 (2001)
E.A. Eugster, M. Fisch, E.C. Walvoord, L.A. DiMeglio, O.H. Pescovitz, Low hemoglobin levels in children with in idiopathic growth hormone deficiency. Endocrine 18, 135–136 (2002)
S. Bergamaschi, C. Giavoli, E. Ferrante, A. Lania, R. Rusconi, A. Spada, P. Beck-Peccoz, Growth hormone replacement therapy in growth hormone deficient children and adults: effects on hemochrome. J. Endocrinol. Invest. 29, 399–404 (2006)
R. Miniero, F. Altomare, M. Rubino, P. Matarazzo, C. Montanari, A. Petri, G. Raiola, G. Bona, Effect of recombinant human growth hormone (rhGH) on hemoglobin concentration in children with idiopathic growth hormone deficiency-related anemia. J. Pediatr. Hematol. Oncol. 34, 407–411 (2012)
E.R. Christ, M.H. Cummings, N.B. Westwood, B.M. Sawyer, T.C. Pearson, P.H. Sönksen, D.L. Russell-Jones, The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency. J. Clin. Endocrinol. Metab. 82, 2985–2990 (1997)
M.P. Kawa, I. Stecewicz, K. Piecyk, E. Pius-Sadowska, E. Paczkowska, D. Rogińska, A. Sobuś, K. Łuczkowska, E. Gawrych, E. Petriczko, M. Walczak, B. Machaliński, Effects of growth hormone therapeutic supplementation on hematopoietic stem/progenitor cells in children with growth hormone deficiency: focus on proliferation and differentiation capabilities. Endocrine 50, 162–175 (2015)
H. Kotzmann, M. Riedl, M. Clodi, U. Barnas, A. Kaider, P. Höcker, A. Luger, The influence of growth hormone substitution therapy on erythroid and myeloid progenitor cells and on peripheral blood cells in adult patients with growth hormone deficiency. Eur. J. Clin. Invest. 26, 1175–1181 (1996)
W. Savino, M. Dardenne, Pleiotropic modulation of thymic functions by growth hormone: from physiology to therapy. Curr. Opin. Pharmacol. 10, 434–442 (2010)
M. Sohmiya, I. Kanazawa, Y. Kato, Effect of recombinant human GH on circulating granulocyte colony-stimulating factor and neutrophils in patients with adult GH deficiency. Eur. J. Endocrinol. 152, 211–215 (2005)
S.M. Ten Have, A.J. van der Lely, S.W. Lamberts, Increase in haemoglobin concentrations in growth hormone deficient adults during human recombinant growth hormone replacement therapy. Clin. Endocrinol. (Oxf.) 47, 565–570 (1997)
G.L. Spadoni, P. Rossi, W. Ragno, E. Galli, S. Cianfarani, C. Galasso, B. Boscherini, Immune function in growth hormone-deficient children treated with biosynthetic growth hormone. Acta Paediatr. Scand. 80, 75–79 (1991)
R. Manfredi, F. Tumietto, L. Azzaroli, A. Zucchini, F. Chiodo, G. Manfredi, Growth hormone (GH) and the immune system: impaired phagocytic function in children with idiopathic GH deficiency is corrected by treatment with biosynthetic GH. J. Pediatr. Endocrinol. 7, 245–251 (1994)
C. Meazza, I. Bonomelli, S. Pagani, P. Travaglino, K. Laarej, F. Cantoni, M. Bozzola, Effect of human recombinant growth hormone therapy on circulating levels of erythropoietin and granulocyte-colony stimulating factor in short children. J. Pediatr. Endocrinol. Metab. 22, 837–843 (2009)
Y. Xu, S. Wang, M. Shen, Z. Zhang, S. Chen, F. Chen, M. Chen, D. Zeng, A. Wang, J. Zhao, T. Cheng, Y. Su, J. Wang, hGH promotes megakaryocyte differentiation and exerts a complementary effect with c-Mpl ligands on thrombopoiesis. Blood 123, 2250–2260 (2014)
Growth Hormone Research Society, Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J. Clin. Endocrinol. Metab. 85, 3990–3993 (2000)
E. Cacciari, S. Milani, A. Balsamo, E. Spada, G. Bona, L. Cavallo, F. Cerutti, L. Gargantini, N. Greggio, G. Tonini, A. Cicognani, Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J. Endocrinol. Invest. 29, 581–593 (2006)
S.H. Orkin, D.E. Fisher, A.T. Look, S.E. Lux, D. Ginsburg, D.G. Nathan, Nathan and Oski’s hematology of infancy and childhood (Saunders, Philadelphia, 2009)
O. Livnah, E.A. Stura, D.L. Johnson, S.A. Middleton, L.S. Mulcahy, N.C. Wrighton, W.J. Dower, L.K. Jolliffe, I.A. Wilson, Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A. Science 273, 464–471 (1996)
D. Capalbo, G. Mattace Raso, A. Esposito, R. Di Mase, F. Barbieri, R. Meli, D. Bruzzese, M. Salerno, Cluster of cardiometabolic risk factors in children with GH deficiency: a prospective, case-control study. Clin. Endocrinol. (Oxf.) 80, 856–862 (2014)
I.M. van der Sluis, A.M. Boot, W.C. Hop, Y.B. De Rijke, E.P. Krenning, S.M. de Muinck Keizer-Schrama, Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: a 6-year follow-up study. Horm. Res. 58, 207–214 (2002)
D.A. Weigent, Lymphocyte GH-axis hormones in immunity. Cell. Immunol. 285, 118–132 (2013)
G. Morrhaye, H. Kermani, J.J. Legros, F. Baron, Y. Beguin, M. Moutschen, R. Cheynier, H.J. Martens, V. Geenen, Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients. PLoS ONE (2009). doi:10.1371/journal.pone.0005668
O. Serri, P. St-Jacques, M. Sartippour, G. Renier, Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy. J. Clin. Endocrinol. Metab. 84, 58–63 (1999)
S.B. Sneppen, H. Mersebach, H. Ullum, U. Feldt-Rasmussen, Immune function during GH treatment in GH-deficient adults: an 18-month randomized, placebo-controlled, double-blinded trial. Clin. Endocrinol. (Oxf.) 57, 787–792 (2002)
I. Vigliano, A. Fusco, L. Palamaro, G. Aloj, E. Cirillo, M.C. Salerno, C. Pignata, γ Chain transducing element: a shared pathway between endocrine and immune system. Cell. Immunol. 269, 10–15 (2011)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Esposito, A., Capalbo, D., De Martino, L. et al. Long-term effects of growth hormone (GH) replacement therapy on hematopoiesis in a large cohort of children with GH deficiency. Endocrine 53, 192–198 (2016). https://doi.org/10.1007/s12020-015-0781-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-015-0781-9